AKT1 and hepatocellular carcinoma: In addition, NKAP functions as an oncogene in breast cancer, hepatocellular carcinoma, and renal cell carcinoma through the protein kinase B/mammalian target of the rapamycin signaling pathway (Liu et al., 2018; Song et al., 2019; Ma et al., 2020).